AGOVIRAX is indicated for prophylaxis and supportive treatment of viral infections of the respiratory tract:

  • Agovirax reduces the viral load (number of viruses) in mucus membranes by more than 90%. [1].
  • Agovirax shortens the duration of the disease on average by 2.1 days. [2]
  • Agovirax significantly lowers frequency of relapses. [2]
  • Agovirax reduces the common cold symptoms. [1].

Agovirax is approved for use in adults and children from 1 year of age.